Immunotherapy cocktail aims to boost immune attack on prostate tumors before surgery
Disease control
Recruiting now
This phase 2 trial is testing whether the immunotherapy drug atezolizumab, alone or combined with etrumadenant or tocilizumab, can boost immune cell activity in prostate tumors before surgical removal. About 68 men with localized prostate cancer will receive treatment before radi…
Phase: PHASE2 • Sponsor: David Oh • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC